Current Strategies for the Treatment of Hereditary Tyrosinemia Type I

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.8, Iss.1, 2006-01, pp. : 47-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitisinone in the Treatment of Hereditary Tyrosinaemia Type 1

By McKiernan Patrick J.

Drugs, Vol. 66, Iss. 6, 2006-01 ,pp. : 743-750

Adis International

Access to resources Recommend Favorite

A Perspective on the Current Strategies for the Treatment of Obesity

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 5, 2004-10 ,pp. : 341-356

Bentham Science Publishers

Access to resources Recommend Favorite

Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1

By Santra Saikat Baumann Ulrich

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1229-1236

Informa Healthcare

Access to resources Recommend Favorite

Acute Sinusitis in Children: Current Treatment Strategies

By Contopoulos-Ioannidis D.G.

Pediatric Drugs, Vol. 5, Iss. 2, 2003-01 ,pp. : 71-80

Adis International

Access to resources Recommend Favorite

Polycythaemia Vera and Essential Thrombocythaemia: Current Treatment Strategies

By Penninga Elisabeth I. Bjerrum Ole W.

Drugs, Vol. 66, Iss. 17, 2006-01 ,pp. : 2173-2187

Adis International

Access to resources Recommend Favorite